Article info

Download PDFPDF
Recently approved treatment options for patients with metastatic triple-negative and HER2-neu-positive breast cancer

Authors

  1. Correspondence to Dr Alexander Philipovskiy, Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA; Alexander.Philipovskiy{at}ttuhsc.edu
View Full Text

Citation

Ghafouri SR, Guvvala S, Jones C, et al
Recently approved treatment options for patients with metastatic triple-negative and HER2-neu-positive breast cancer

Publication history

  • Accepted February 24, 2022
  • First published June 15, 2022.
Online issue publication 
August 15, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.